28
Oct
2025

Hainan Zhonghe Pharmaceutical Co., Ltd.

Exhibitor at CPHI Frankfurt 2025 stand 4.1A14, Finished Dosage Formulations
About Us

Hainan Zhonghe Pharmaceutical Co., Ltd, established in 1995, is the first high-tech enterprise specialized in development, production and marketing of peptide drugs in China. Our plants are equipped with the most advanced peptide synthesis and purification facilities. Our therapeutic areas oncology & immune system, gastroenterology, etc.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 4.1A14, Finished Dosage Formulations

Products Featured at CPHI Frankfurt 2025

  • Entecavir Dispersible Tablets and Capsules

    Product Entecavir Dispersible Tablets and Capsules

    Strength: 0.5 mg Entecavir is used to treat chronic (long-term) hepatitis B infection (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have liver damage.
  • Eptifibatide Injection

    Product Eptifibatide Injection

    Strength: 20 mg/10 ml It is used for the prevention of early myocardial infarction in adults presenting with unstable angina or non-Q-wave myocardial infarction, and for platelet aggregation
  • Atosiban Acetate Injection

    Product Atosiban Acetate Injection

    Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant to halt premature labor. Atosiban Acetate Injection is indicated to delay imm...
  • Thymalfasin for Injection

    Product Thymalfasin for Injection

    • Thymosin α1 for Injection is a purified, sterile lyophilized preparation of chemically synthesized thymosin alpha 1. It is supplied in single use vials containing 1.6 mg of lyophilized thymosin alpha 1 per vial. This drug is indicated for the treatment of chronic hepatitis B in patients 18 years of age ...
  • Thymopentin for injection

    Product Thymopentin for injection

    Thymopentin is a synthetic pentapeptide which is the active site of the naturally occurring hormone thymopoietin with immunomodulating properties. Thymopentin enhances the production of thymic T cells and may help restore immunocompetence in immunosuppressed subjects. 【Indications】
    (1) Patients wit...